Skip to main content
. 2019 May 10;6(5-6):312–316. doi: 10.18632/oncoscience.481

Table 1. Datasets publically available from cBioPortal and GENIE Project that were used, by disease group, with overall sample size.

Disease Dataset Sample Size Total
Bladder BLCA_TCGA_PAN_CAN_ATLAS_2018 408 1,181
DFCI-ONCOPANEL-3 69
MSK-IMPACT341 95
MSK-IMPACT410 326
MSK-IMPACT468 143
UTUC_MSKCC_2013 84
VICC-01-T5A 3
VICC-01-T7 53
Breast BRCA_IGR_2015 216 3,442
BRCA_MBCPROJECT_WAGLE_2017 157
DFCI-ONCOPANEL-3 304
MSK-IMPACT341 410
MSK-IMPACT410 1,021
MSK-IMPACT468 1,076
VICC-01-T5A 87
VICC-01-T7 171
Colorectal CRC_MSK_2018 1,134 3,272
DFCI-ONCOPANEL-3 351
MSK-IMPACT341 209
MSK-IMPACT410 906
MSK-IMPACT468 465
VICC-01-T5A 47
VICC-01-T7 160
Esophagogastric DFCI-ONCOPANEL-3 146 1,458
EGC_MSK_2017 341
ESCA_TCGA_PAN_CAN_ATLAS_2018 182
MSK-IMPACT341 122
MSK-IMPACT410 216
MSK-IMPACT468 106
STES_TCGA_PUB 288
VICC-01-T5A 11
VICC-01-T7 46
HNSCC DFCI-ONCOPANEL-3 83 1, 010
HNC_MSKCC_2016 151
HNSC_TCGA_PAN_CAN_ATLAS_2018 517
MSK-IMPACT341 37
MSK-IMPACT410 132
MSK-IMPACT468 75
VICC-01-T5A 6
VICC-01-T7 9
Melanoma 906
MSK-IMPACT341 64
MSK-IMPACT410 364
MSK-IMPACT468 214
VICC-01-T7 140
VICC-01-T5A 37
Ovarian DFCI-ONCOPANEL-3 125 1,065
MSK-IMPACT341 88
MSK-IMPACT410 139
MSK-IMPACT468 155
OV_TCGA_PUB 489
VICC-01-T5A 31
VICC-01-T7 38
Prostate DFCI-ONCOPANEL-3 97 2,251
MSK-IMPACT341 153
MSK-IMPACT410 569
MSK-IMPACT468 377
PRAD_FHCRC 149
PRAD_MICH 61
PRAD_MSKCC 194
PRAD_SU2C_2015 150
PRAD_MSKCC_2017 501
Uterine DFCI-ONCOPANEL-3 120 1,085
MSK-IMPACT341 119
MSK-IMPACT410 258
MSK-IMPACT468 326
UCEC_TCGA_PUB 232
VICC-01-T7 19
VICC-01-T5A 11